Civic Intelligence

California Institute for Immunology And

EIN 87-2786093 • 501(c)3 • Los Angeles, CA

Profile

To harness the power of the human immune system and advanced computing technologies to create and translate scientific discoveries into next generation vaccines and therapies for prevention, control and cure of chronic diseases, enabling longer and healthier lives.

11755 Wilshire Boulevard 1400Los Angeles, CA 90025

www.calimmunology.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

74th percentile

0.29x

Higher debt load relative to assets than 74% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

73rd percentile

0.30x

Higher debt load relative to revenue than 73% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Net Margin

90th percentile

54%

Higher net margin than 90% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

40th percentile

$0

Higher top officer pay than 40% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Asset Growth

99th percentile

425%

Faster asset growth than 99% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

23rd percentile

-9.8%

Faster revenue growth than 23% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets74th percentile

Assets

Up

$1,008,545

Up $816,261 (+425%) from 2023

Liabilities

Up

$295,841

Up $278,469 (+1603%) from 2023

Net Assets

Up

$712,704

Up $537,792 (+307%) from 2023

Operations
Liabilities / Revenue73rd percentileNet Margin90th percentile

Revenue

Down

$1,000,000

Down $108,746 (-9.8%) from 2023

Expenses

Down

$462,208

Down $471,626 (-51%) from 2023

Net Income

Up

$537,792

Up $362,880 (+207%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth99th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$1.5M$1.0M$500K$0Assets 2023: $192,284Liabilities 2023: $17,372Net Assets 2023: $174,9122023Assets 2024: $1,008,545Liabilities 2024: $295,841Net Assets 2024: $712,7042024

Highlighted filing

2024

Assets$1,008,545
Liabilities$295,841
Net Assets$712,704
Open 2024 Filing

Operations Trend

Revenue Growth23rd percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$1.5M$1.0M$500K$0Revenue 2023: $1,108,746Expenses 2023: $933,834Net Income 2023: $174,9122023Revenue 2024: $1,000,000Expenses 2024: $462,208Net Income 2024: $537,7922024

Highlighted filing

2024

Revenue$1,000,000
Expenses$462,208
Net Income$537,792
Open 2024 Filing

Filings

Most recent year

2024 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$1,008,545
Liabilities
$295,841
Net assets
$712,704
Revenue
$1,000,000
Expenses
$462,208
Net income
$537,792
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$1.01$0.30$0.71$1.00$0.46$0.54
2023Detailed filing. Detailed filing data is available for this year.$0.19$0.02$0.17$1.11$0.93$0.17
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jul 1, 2023 to Jun 30, 2024
Signed
May 12, 2025
Return Version
2023v6.0
Gross Receipts
$1,000,000
Mission and Program Overview

Mission

To harness the power of the human immune system and advanced computing technologies to create and translate scientific discoveries into next generation vaccines and therapies for prevention, control and cure of chronic diseases, enabling longer and healthier lives.

Medical sciences research institute dedicated to the study of the immune system

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$192,284$1,008,545▲ $816,261
Rtn Earn Endowment Incm Other Fnds$174,912$712,704▲ $537,792
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$192,284$1,008,545▲ $816,261
Liabilities
Accounts Payable and Accrued Expenses$17,372$295,841▲ $278,469
Total Liabilities$17,372$295,841▲ $278,469
Net Assets / Fund Balance
Total Net Assets Fund Balance$174,912$712,704▲ $537,792
Total Liabilities and Net Assets / Fund Balance$192,284$1,008,545▲ $816,261
Compensation and Service Providers
Top Officer Pay40th percentile

Board Members and Trustees

NameTitle
Gary MichelsonBoard Chair/director
Eric EsrailianPresident/director
Arie BelldegrunDirector
Michael MilkenDirector
Sean ParkerDirector
Meyer LuskinTreasurer/secretary/director

Highest Paid Contractors

ContractorServicesLocationCompensation
Arnold & Porter Kaye Scholer LLPLegal601 MASSACHUSETTS AVE NW, Washington, DC 20001$116,631
Revenue and Support

Revenue Composition

Contributions and Grants
$1,000,000
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$1,000,000
Change in Net Assets
$537,792
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$462,208
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Legal$340,563$85,141-$425,704
Fees for Services Accounting-$36,304-$36,304
Office Expenses-$200-$200
Total Functional Expenses$340,563$121,645$0$462,208
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
Yes
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 7A

“The corporation's designator, california institute for immunology and immunotherapy founders llc, has the power to remove directors and fill vacancies on the board.”

Form 990, Part VI, Section A, Line 7B

“Any amendments to the corporation's articles of incorporation and bylaws are subject to the written consent of the corporation's designator, california institute for immunology and immunotherapy founders llc.”

Form 990, Part VI, Section B, Line 11B

“Form 990 is reviewed by the audit committee and legal counsel and then distributed to the board of directors prior to filing.”

Form 990, Part VI, Section B, Line 12C

“The institute has a conflict of interest policy that requires directors, officers, key employees and other designated individuals to disclose if they have a personal interest or relationship in a transaction involving the institute, whether directly or indirectly through a family member, controlled entity or business or investment relationship. Any individual with a personal interest or relationship in a transaction involving the institute must be recused from the discussions and approval for that transaction. The transaction must be reviewed by disinterested persons who do not have a personal interest in the transaction under review, and such disinterested persons may approve the transaction after determining that the terms are fair and reasonable to the institute. The institute may also consider whether there are alternative transactions or arrangements that are reasonably available under the circumstances that do not present a potential conflict of interest.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents, conflict of interest policy and financial statements are made available to the public upon request when required by federal or state law.”

Filing and Contact Details

Filer

Filer Name
California Institute for Immunology and
EIN
87-2786093
Phone
6508047100
Address
11755 WILSHIRE BOULEVARD 1400, LOS ANGELES, CA 90025

Signing Officer

Name
Eric Esrailian
Title
President
Phone
6508047100
Signed
2025-05-12
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Eric Esrailian
Formed
2021
Legal Domicile
CA
Voting Board Members
6
Independent Board Members
6
Employees
0
Volunteers
10

Preparer

Firm
Apercen Partners LLC
Address
314 LYTTON AVE, PALO ALTO, CA 94301
Preparer
Tom M Van Loben Sels
Phone
6508047100
Raw XML Appendix351 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt017372
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0295841
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0MEDICAL SCIENCES RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE IMMUNE SYSTEM
IRS990/AllOtherContributionsAmt01000000
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0APERCEN PARTNERS LLC
IRS990/BooksInCareOfDetail/PhoneNum06508047100
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0314 LYTTON AVE
IRS990/BooksInCareOfDetail/USAddress/CityNm0PALO ALTO
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd094301
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt0192284
IRS990/CashNonInterestBearingGrp/EOYAmt01008545
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt01
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/ContractorCompensationGrp/CompensationAmt0116631
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt0601 MASSACHUSETTS AVE NW
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0WASHINGTON
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0DC
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd020001
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0ARNOLD & PORTER KAYE SCHOLER LLP
IRS990/ContractorCompensationGrp/ServicesDesc0LEGAL
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01000000
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt0462208
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0537792
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0462208
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01000000
IRS990/DecisionsSubjectToApprovaInd01
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0THE INSTITUTE IS A MEDICAL SCIENCES RESEARCH INSTITUTE DEDICATED TO THE STUDY OF THE IMMUNE SYSTEM AND ITS VARIED ROLES IN THE PATHOGENESIS AND POTENTIAL TREATMENT OF A WIDE VARIETY OF DISEASES, WITH A MISSION TO DEEPLY DECODE THE WORKINGS OF THE HUMAN IMMUNE SYSTEM TO PROMOTE HEALTH, COMBAT DISEASE AND PROLONG LIFE. THE INSTITUTE WAS ESTABLISHED TO CREATE A MULTIDISCIPLINARY MEDICAL RESEARCH INSTITUTE TO COORDINATE RESEARCH INTO THE HUMAN IMMUNE SYSTEM ACROSS UNIVERSITIES AND RESEARCH INSTITUTIONS IN CALIFORNIA. THE INSTITUTE ALSO PLANS TO ENGAGE IN THE CONTINUOUS AND ACTIVE CONDUCT OF MEDICAL RESEARCH IN COLLABORATION WITH VARIOUS NONPROFIT HOSPITALS.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd01
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0340563
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt036304
IRS990/FeesForServicesAccountingGrp/TotalAmt036304
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt085141
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0340563
IRS990/FeesForServicesLegalGrp/TotalAmt0425704
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt01.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRltdOrgRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt05.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/PersonNm0GARY MICHELSON
IRS990/Form990PartVIISectionAGrp/PersonNm1ERIC ESRAILIAN
IRS990/Form990PartVIISectionAGrp/PersonNm2MEYER LUSKIN
IRS990/Form990PartVIISectionAGrp/PersonNm3ARIE BELLDEGRUN
IRS990/Form990PartVIISectionAGrp/PersonNm4MICHAEL MILKEN
IRS990/Form990PartVIISectionAGrp/PersonNm5SEAN PARKER
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/TitleTxt0BOARD CHAIR/DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1PRESIDENT/DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER/SECRETARY/DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02021
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt06
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt01000000
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt06
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt04
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TO HARNESS THE POWER OF THE HUMAN IMMUNE SYSTEM AND ADVANCED COMPUTING TECHNOLOGIES TO CREATE AND TRANSLATE SCIENTIFIC DISCOVERIES INTO NEXT GENERATION VACCINES AND THERAPIES FOR PREVENTION, CONTROL AND CURE OF CHRONIC DISEASES, ENABLING LONGER AND HEALTHIER LIVES.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt0174912
IRS990/NetAssetsOrFundBalancesEOYAmt0712704
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0200
IRS990/OfficeExpensesGrp/TotalAmt0200
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0ERIC ESRAILIAN
IRS990/ProfessionalFundraisingInd00
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01108746
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt0933834
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0174912
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt0933834
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt01108746
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0537792
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt0174912
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt0712704
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt0THE 2020 TAX YEAR, WHICH IS THE ORGANIZATION'S FISCAL YEAR ENDING JUNE 30, 2021, WAS A SHORT YEAR, COVERING THE PERIOD APRIL 8, 2021, THROUGH JUNE 30, 2021, DUE TO IT BEING THE ORGANIZATION'S FIRST YEAR IN EXISTENCE.
IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc0SCHEDULE A, PART II - EXPLANATION FOR SHORT YEAR
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01000000
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01108746
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt02108746
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt01150921
IRS990ScheduleA/SubstantialContributorsTotAmt0957825
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01000000
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01108746
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt02108746
IRS990ScheduleA/TotalSupportAmt02108746
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE CORPORATION'S DESIGNATOR, CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY FOUNDERS LLC, HAS THE POWER TO REMOVE DIRECTORS AND FILL VACANCIES ON THE BOARD.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ANY AMENDMENTS TO THE CORPORATION'S ARTICLES OF INCORPORATION AND BYLAWS ARE SUBJECT TO THE WRITTEN CONSENT OF THE CORPORATION'S DESIGNATOR, CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY FOUNDERS LLC.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2FORM 990 IS REVIEWED BY THE AUDIT COMMITTEE AND LEGAL COUNSEL AND THEN DISTRIBUTED TO THE BOARD OF DIRECTORS PRIOR TO FILING.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE INSTITUTE HAS A CONFLICT OF INTEREST POLICY THAT REQUIRES DIRECTORS, OFFICERS, KEY EMPLOYEES AND OTHER DESIGNATED INDIVIDUALS TO DISCLOSE IF THEY HAVE A PERSONAL INTEREST OR RELATIONSHIP IN A TRANSACTION INVOLVING THE INSTITUTE, WHETHER DIRECTLY OR INDIRECTLY THROUGH A FAMILY MEMBER, CONTROLLED ENTITY OR BUSINESS OR INVESTMENT RELATIONSHIP. ANY INDIVIDUAL WITH A PERSONAL INTEREST OR RELATIONSHIP IN A TRANSACTION INVOLVING THE INSTITUTE MUST BE RECUSED FROM THE DISCUSSIONS AND APPROVAL FOR THAT TRANSACTION. THE TRANSACTION MUST BE REVIEWED BY DISINTERESTED PERSONS WHO DO NOT HAVE A PERSONAL INTEREST IN THE TRANSACTION UNDER REVIEW, AND SUCH DISINTERESTED PERSONS MAY APPROVE THE TRANSACTION AFTER DETERMINING THAT THE TERMS ARE FAIR AND REASONABLE TO THE INSTITUTE. THE INSTITUTE MAY ALSO CONSIDER WHETHER THERE ARE ALTERNATIVE TRANSACTIONS OR ARRANGEMENTS THAT ARE REASONABLY AVAILABLE UNDER THE CIRCUMSTANCES THAT DO NOT PRESENT A POTENTIAL CONFLICT OF INTEREST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST WHEN REQUIRED BY FEDERAL OR STATE LAW.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION A, LINE 7A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION A, LINE 7B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART VI, SECTION B, LINE 12C
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PART VI, SECTION C, LINE 19
IRS990ScheduleR/AssetExchangeInd00
IRS990ScheduleR/AssetPurchaseFromOtherOrgInd00
IRS990ScheduleR/AssetSaleToOtherOrgInd00
IRS990ScheduleR/DivRelatedOrganizationInd00
IRS990ScheduleR/GiftGrntCapContriFromOthOrgInd00
IRS990ScheduleR/GiftGrntOrCapContriToOthOrgInd00
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/DirectControllingNACd0N/A
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/DisproportionateAllocationsInd00
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/EIN0882383224
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/GeneralOrManagingPartnerInd00
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/LegalDomicileStateCd0CA
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/PredominantIncomeTypeTxt0NONE
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/PrimaryActivitiesTxt0PROFESSIONAL SERVICES
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/RelatedOrganizationName/BusinessNameLine1Txt0CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND IMMUNOTHERAPY FOUNDERS LLC
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/USAddress/AddressLine1Txt0314 LYTTON AVE
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/USAddress/CityNm0PALO ALTO
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/USAddress/StateAbbreviationCd0CA
IRS990ScheduleR/IdRelatedOrgTxblPartnershipGrp/USAddress/ZIPCd094301
IRS990ScheduleR/LoansOrGuaranteesFromOthOrgInd00
IRS990ScheduleR/LoansOrGuaranteesToOtherOrgInd00
IRS990ScheduleR/PaidEmployeesSharingInd00
IRS990ScheduleR/PerformOfServicesByOtherOrgInd00
IRS990ScheduleR/PerformOfServicesForOthOrgInd00
IRS990ScheduleR/ReceiptOfIntAnntsRntsRyltsInd00
IRS990ScheduleR/ReimbursementPaidByOtherOrgInd00
IRS990ScheduleR/ReimbursementPaidToOtherOrgInd00
IRS990ScheduleR/RentalOfFacilitiesToOthOrgInd00
IRS990ScheduleR/RentalOfFcltsFromOthOrgInd00
IRS990ScheduleR/SharingOfFacilitiesInd00
IRS990ScheduleR/TransferFromOtherOrgInd00
IRS990ScheduleR/TransferToOtherOrgInd00
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0192284
IRS990/TotalAssetsEOYAmt01008545
IRS990/TotalAssetsGrp/BOYAmt0192284
IRS990/TotalAssetsGrp/EOYAmt01008545
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt01000000
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt0121645
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0340563
IRS990/TotalFunctionalExpensesGrp/TotalAmt0462208
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt017372
IRS990/TotalLiabilitiesEOYAmt0295841
IRS990/TotalLiabilitiesGrp/BOYAmt017372
IRS990/TotalLiabilitiesGrp/EOYAmt0295841
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0174912
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0712704
IRS990/TotalOtherCompensationAmt00
IRS990/TotalProgramServiceExpensesAmt0340563
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt00
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt01000000
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt010
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0192284
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt01008545
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt011755 WILSHIRE BOULEVARD 1400
IRS990/USAddress/CityNm0LOS ANGELES
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd090025
IRS990/VotingMembersGoverningBodyCnt06
IRS990/VotingMembersIndependentCnt06
IRS990/WebsiteAddressTxt0HTTPS://WWW.CALIMMUNOLOGY.ORG
IRS990/WhistleblowerPolicyInd01
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ERIC ESRAILIAN
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum06508047100
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-05-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CALIFORNIA INSTITUTE FOR IMMUNOLOGY AND
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0IMMUNOTHERAPY
ReturnHeader/Filer/BusinessNameControlTxt0INST
ReturnHeader/Filer/EIN0872786093
ReturnHeader/Filer/PhoneNum06508047100
ReturnHeader/Filer/USAddress/AddressLine1Txt011755 WILSHIRE BOULEVARD 1400
ReturnHeader/Filer/USAddress/CityNm0LOS ANGELES
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd090025
ReturnHeader/IRSResponsiblePrtyInfoCurrInd01
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0262246506
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0APERCEN PARTNERS LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0314 LYTTON AVE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0PALO ALTO
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd094301
ReturnHeader/PreparerPersonGrp/PhoneNum06508047100
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0TOM M VAN LOBEN SELS
ReturnHeader/ReturnTs02025-05-12T18:24:49-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02023-07-01
ReturnHeader/TaxPeriodEndDt02024-06-30
ReturnHeader/TaxYr02023

Document Assets

No mirrored PDF or thumbnail assets are attached yet.